Price
CHART BY
Frequently asked questions
What is Outset Medical's market capitalization?
The market capitalization of Outset Medical is $370.93M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Outset Medical?
Outset Medical's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$29.22. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Outset Medical's stock?
Currently, 5 analysts cover Outset Medical's stock, with a consensus target price of $26.50. Analyst ratings provide insights into the stock's expected performance.
What is Outset Medical's revenue over the trailing twelve months?
Over the trailing twelve months, Outset Medical reported a revenue of $115.27M.
What is the EBITDA for Outset Medical?
Outset Medical's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$85.90M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Outset Medical?
Outset Medical has a free cash flow of -$96.74M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the free float of Outset Medical's shares?
The free float of Outset Medical is 17.25M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $370.93M
- EPS (TTM)
- -$29.22
- Free Float
- 17.25M
- Revenue (TTM)
- $115.27M
- EBITDA (TTM)
- -$85.90M
- Free Cashflow (TTM)
- -$96.74M
Pricing
- 52W span
- $5.851$72.60
Analyst Ratings
The price target is $26.50 and the stock is covered by 5 analysts.
Buy
3
Hold
2
Sell
0
Information
Outset Medical, Inc. engages in the provision of dialysis solutions to patients and healthcare providers. Its product, Tablo Hemodialysis System (Tablo), offers technological advancement enabling novel, transformational dialysis care in acute and home settings. The company was founded in 2003 and is headquartered in San Jose, CA.
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- US6901452069
- Primary Ticker
- OM
Fundamentals & EOD data from FactSet